MedPath

Pilot study: Dystrophyc pathways in human hair follicles after chemotherapy with or without scalp cooling.

Completed
Conditions
Alopecia
Hair loss
10006288
Registration Number
NL-OMON45664
Lead Sponsor
oordwest Ziekenhuisgroep
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- Patients with cancer
- Indication for at least one cycle docetaxel or paclitaxel
- Age 18 years or more
- Written informed consent

Exclusion Criteria

NA

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The expression of apoptotic markers in the dystrophic pathway involved in<br /><br>chemotherapy induced alopecia. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Differences in the dystrophic pathway in patients with and without scalp<br /><br>cooling.</p><br>
© Copyright 2025. All Rights Reserved by MedPath